Skip to content
StockMarketAgent
Sector pending / In Vitro and In Vivo Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/12V stock hub

FRA/12V has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

FRA/12Vis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
2.7B
Frankfurt Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
FRA/12V
In the news

Latest news · FRA/12V

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E22.5
P25 n/aP50 n/aP75 n/a
Trailing P/E35.9
P25 n/aP50 n/aP75 n/a
ROE6.9
P25 n/aP50 n/aP75 n/a
ROIC8.5
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All FRA/12V market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
196
Groups with data
11
Currency
USD
Showing 196 of 196 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
United States
Country code
DE
Employees
755
Employees Change
9%
Employees Change Percent
1.1
Enterprise value
EUR 2.4B
Exchange
Frankfurt Stock Exchange
Financial currency
USD
First seen
2026-05-10
Industry
In Vitro and In Vivo Diagnostic Substances
Last refreshed
2026-05-10
Market cap
EUR 2.7B
Price
EUR 34.37
Price currency
EUR
Rev Per Employee
622,322.79x
Sic
2835
Symbol
fra/12V
Website
https://www.veracyte.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

11
MetricValue
Earnings Yield
2.79%
EV Earnings
31.45x
EV/EBIT
34.15x
EV/EBITDA
22.62x
EV/FCF
17.82x
EV/Sales
5.22x
FCF yield
4.92%
Forward P/E
22.52x
P/B ratio
2.35x
P/E ratio
35.9x
P/S ratio
5.83x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

22
MetricValue
EBIT Margin
15.27%
EBITDA Margin
19.24%
FCF margin
28.67%
Gross margin
72.91%
Gross Profit
EUR 342.6M
Gross Profit Growth
21.01%
Gross Profit Growth Q
26.52%
Gross Profit Growth3 Y
22.24%
Gross Profit Growth5 Y
37.45%
Net Income
EUR 76.3M
Net Income Growth
166.31%
Net Income Growth Q
307.37%
Pretax Margin
16.75%
Profit Margin
16.25%
Profit Per Employee
EUR 101,104
ROA
3.76
Roa5y
-1.08
ROCE
5.99
ROE
6.93
Roe5y
-2.57
ROIC
8.53
Roic5y
-2.74

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

16
MetricValue
Cagr10y
22.56%
Cagr1y
29.23%
Cagr3y
19.38%
Cagr5y
-1.03%
EPS Growth
160.6
EPS Growth Q
288.9
FCF Growth
98.01%
FCF Growth Q
810.33%
FCF Growth3 Y
179.09%
OCF Growth
85.81%
OCF Growth Q
556.75%
OCF Growth3 Y
126.84%
Revenue Growth
16.91x
Revenue Growth Q
21.49x
Revenue Growth3 Y
20.3x
Revenue Growth5 Y
34.5x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
EUR 0.39
Assets
EUR 1.2B
Cash
EUR 380.8M
Current Assets
EUR 442.8M
Current Liabilities
EUR 47.6M
Debt
EUR 34.1M
Debt EBITDA
EUR 0.31
Debt Equity
EUR 0.03
Debt FCF
EUR 0.25
Equity
EUR 1.2B
Interest Coverage
82,757.6
Liabilities
EUR 79.8M
Long Term Assets
EUR 803M
Long Term Liabilities
EUR 32.2M
Net Cash
EUR 346.7M
Net Cash By Market Cap
EUR 12.65
Net Cash Growth
68.77%
Net Debt EBITDA
EUR -3.84
Net Debt Equity
EUR -0.3
Net Debt FCF
EUR -2.57
Tangible Book Value
EUR 426.2M
Tangible Book Value Per Share
EUR 5.34

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
9.31
Inventory Turnover
6.43
Net Working Capital
EUR 27.2M
Quick ratio
8.72
Working Capital
EUR 404.2M
Working Capital Turnover
EUR 1.21

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-1.76%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

35
MetricValue
10Y total return
664.63%
1Y total return
29.21%
200-day SMA
30.37
3Y total return
70.15%
50-day SMA
28.7
50-day SMA vs 200-day SMA
50under200
5Y total return
-5.06%
All Time High
67
All Time High Change
-48.7%
All Time High Date
2021-02-10
All Time Low
3.95
All Time Low Change
770.13%
All Time Low Date
2016-03-24
ATR
0.97
Ch YTD
-5.06
High
34.37
High52
42.6
High52 Date
2025-11-26
High52ch
-19.32%
Low
34.37
Low52
19.5
Low52 Date
2025-07-22
Low52ch
76.26%
Ma50ch
19.74%
Price vs 200-day SMA
13.19%
RSI
70.74
RSI Monthly
55.16
RSI Weekly
57.43
Sharpe ratio
0.61x
Sortino ratio
1.12
Total Return
-1.76%
Tr YTD
-5.06
Tr1m
25.03%
Tr1w
23.28%
Tr3m
17.71%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

4
MetricValue
Operating Income
EUR 71.8M
Operating Income Growth
187.2
Operating Income Growth Q
679.8
Operating margin
15.27

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
79,351,769%
Shares Insiders
0.51%
Shares Institutions
110.63%
Shares Qo Q
-0.09%
Shares Yo Y
1.76%
Short Ratio
6.82

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

55
MetricValue
Adjusted FCF
EUR 95.3M
Average Volume
17.55x
Bv Per Share
14.61
CAPEX
EUR -9.4M
Ch10y
664.6
Ch1m
25.03
Ch1w
23.28
Ch1y
29.21
Ch3m
17.71
Ch3y
70.15
Ch5y
-5.06
Ch6m
-3.99
Change
-0.69%
Change From Open
0
Close
34.61
Days Gap
-0.69
Depreciation Amortization
18,216,767.6
Earnings Date
2026-05-05
EBIT
EUR 71.8M
EBITDA
EUR 90.4M
EPS
EUR 0.94
F Score
7
FCF
EUR 134.7M
FCF EV Yield
5.61x
Financing CF
-3,787,499
Fiscal Year End
December
Founded
2,006
Goodwill
650,517,440.1
Graham Number
17.75028
Graham Upside
-48.36
Income Tax
EUR 2.4M
Investing CF
-74,025,790
Is Primary Listing
0
Last Earnings Date
2026-05-05
Last Report Date
2026-03-31
Ma150
32.16
Ma150ch
6.87%
Ma20
28.85
Ma20ch
19.15%
Net CF
66,806,384
Open
34.37
P FCF Ratio
20.34
P OCF Ratio
19.01
Ppne
49,620,192.4
Price Date
2026-05-08
Price EBITDA
EUR 30.32
Ptbv Ratio
6.43
Relative Volume
7.62x
Revenue
469,853,704x
SBC By Revenue
8.38x
Share Based Comp
39,378,889
Tax By Revenue
0.5x
Tax Rate
3.01%
Tr6m
-3.99%
Z Score
17.95
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does FRA/12V pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/12V stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+29.2%
S&P 500 1Y: n/a
3Y total return
+70.1%
S&P 500 3Y: n/a
5Y total return
-5.1%
S&P 500 5Y: n/a
10Y total return
+664.6%
S&P 500 10Y: n/a
Ownership

Who owns FRA/12V?

Insider, institutional, and short-interest positioning.

Institutional ownership
+110.6%
Share of float held by funds and institutions
Insider ownership
+0.5%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
6.8 days to cover
Y/Y dilution
+1.8%
Negative means the company is buying back shares.
Technical

FRA/12V momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
70.7
Above 70: short-term overbought
Price vs 200-day MA
+13.2%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
0.61
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About FRA/12V

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/12V stock rating?

fra/12V is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/12V analysis?

The full report lives at /stocks/fra/12V/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/12V?

The latest report frames fra/12V around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/12V page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.